A high degree of heterogeneity is seen in the care of men with penile cancer around the world, stated Philippe E. Spiess, MD, Associate Member of the Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, Florida, and a member of the NCCN Panel on bladder and penile cancers. With the use of non–evidence-based treatment approaches, outcomes can widely vary. To clarify some of the controversies associated with the treatment of penile cancer, NCCN has created inaugural NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for penile cancer, with input from experts in penile cancer from around the world. This comprehensive protocol is intended to establish a foundation to help standardize and optimize the care of patients faced with this potentially disfiguring and lethal cancer.
Alnajjar HM, Lam W, Bolgeri M. Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents. Eur Urol 2012;62:923–928.
Feldman AS, McDougal WS. Long-term outcome of excisional organ sparing surgery for carcinoma of the penis. J Urol 2011;186:1303–1307.
Ficarra V, Zattoni F, Artibani W. Nomogram predictive of pathological inguinal lymph node involvement in patients with squamous cell carcinoma of the penis. J Urol 2006;175:1700–1704.
Tanis PJ, Lont AP, Meinhardt W. Dynamic sentinel node biopsy for penile cancer: reliability of a staging technique. J Urol 2002;168:76–80.
Spiess PE, Izawa JI, Bassett R. Preoperative lymphoscintigraphy and dynamic sentinel node biopsy for staging penile cancer: results with pathological correlation. J Urol 2007;177:2157–2161.
Pagliaro LC, Williams DL, Daliani D. Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol 2010;28:3851–3857.
Leijte JA, Kirrander P, Antonini N. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol 2008;54:161–168.
Graafland NM, Moonen LM, van Boven HH. Inguinal recurrence following therapeutic lymphadenectomy for node positive penile carcinoma: outcome and implications for management. J Urol 2011;185:888–893.